151 related articles for article (PubMed ID: 32564236)
41. The Wessex Fit-4-Cancer Surgery Trial (WesFit): a protocol for a factorial-design, pragmatic randomised-controlled trial investigating the effects of a multi-modal prehabilitation programme in patients undergoing elective major intra-cavity cancer surgery.
West M; Bates A; Grimmett C; Allen C; Green R; Hawkins L; Moyses H; Leggett S; Z H Levett D; Rickard S; Varkonyi-Sepp J; Williams F; Wootton S; Hayes M; P W Grocott M; Jack S
F1000Res; 2021; 10():952. PubMed ID: 36247802
[No Abstract] [Full Text] [Related]
42. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation.
Fadadu PP; Polen-De CL; McGree ME; Weaver AL; Moynagh MR; Takahashi N; Langstraat CL; Cliby WA; Kumar A
Gynecol Oncol; 2021 Jan; 160(1):40-44. PubMed ID: 33109391
[TBL] [Abstract][Full Text] [Related]
43. Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.
Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Ishii H; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Oba K; Ishihara S
Int J Clin Oncol; 2022 Jan; 27(1):141-153. PubMed ID: 34741193
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
46. Exercise prehabilitation program for patients under neoadjuvant treatment for rectal cancer: A pilot study.
Alejo LB; Pagola-Aldazabal I; Fiuza-Luces C; Huerga D; de Torres MV; Verdugo AS; Ortega Solano MJ; Felipe JL; Lucia A; Ruiz-Casado A
J Cancer Res Ther; 2019; 15(1):20-25. PubMed ID: 30880749
[TBL] [Abstract][Full Text] [Related]
47. Prehabilitation for Patients with Cancer Undergoing Radiation Therapy: a Scoping Review.
Harris E; Marignol L
Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):254-264. PubMed ID: 38350785
[TBL] [Abstract][Full Text] [Related]
48. Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis.
Falz R; Bischoff C; Thieme R; Lässing J; Mehdorn M; Stelzner S; Busse M; Gockel I
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2187-2213. PubMed ID: 35695931
[TBL] [Abstract][Full Text] [Related]
49. PRehabIlitatiOn with pReoperatIve exercise and educaTion for patients undergoing major abdominal cancer surgerY: protocol for a multicentre randomised controlled TRIAL (PRIORITY TRIAL).
Steffens D; Young J; Riedel B; Morton R; Denehy L; Heriot A; Koh C; Li Q; Bauman A; Sandroussi C; Ismail H; Dieng M; Ansari N; Pillinger N; O'Shannassy S; McKeown S; Cunningham D; Sheehan K; Iori G; Bartyn J; Solomon M
BMC Cancer; 2022 Apr; 22(1):443. PubMed ID: 35459100
[TBL] [Abstract][Full Text] [Related]
50. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
[TBL] [Abstract][Full Text] [Related]
51. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
52. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy.
Kawakita Y; Motoyama S; Sato Y; Wakita A; Nagaki Y; Imai K; Minamiya Y
World J Surg; 2020 May; 44(5):1559-1568. PubMed ID: 31907570
[TBL] [Abstract][Full Text] [Related]
53. Prehabilitation in elective patients undergoing cardiac surgery: a randomised control trial (THE PrEPS TRIAL) - a study protocol.
Akowuah E; Mathias A; Bardgett M; Harrison S; Kasim AS; Loughran K; Ogundimu E; Trevis J; Wagnild J; Witharana P; Hancock HC; Maier RH
BMJ Open; 2023 Jan; 13(1):e065992. PubMed ID: 36604134
[TBL] [Abstract][Full Text] [Related]
54. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
Jeong SY; Park JW; Nam BH; Kim S; Kang SB; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim DH; Kim JS; Lee HS; Kim JH; Oh JH
Lancet Oncol; 2014 Jun; 15(7):767-74. PubMed ID: 24837215
[TBL] [Abstract][Full Text] [Related]
55. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
56. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
57. Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.
Dietz DW; Dehdashti F; Grigsby PW; Malyapa RS; Myerson RJ; Picus J; Ritter J; Lewis JS; Welch MJ; Siegel BA
Dis Colon Rectum; 2008 Nov; 51(11):1641-8. PubMed ID: 18682881
[TBL] [Abstract][Full Text] [Related]
58. Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancer.
den Boer RB; Jones KI; Ash S; van Boxel GI; Gillies RS; O'Donnell T; Ruurda JP; Sgromo B; Silva MA; Maynard ND
BJS Open; 2020 Oct; 4(5):847-854. PubMed ID: 32841538
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
60. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
